Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Impaired Hepatic Function”

123 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 123 results

Early research (Phase 1)Study completedNCT04293029
What this trial is testing

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Jiangsu HengRui Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT00416702
What this trial is testing

Safety and Pharmacokinetics of Indacaterol in Healthy Subjects and Those With Impaired Liver Function

Who this might be right for
Hepatic Insufficiency
Novartis 32
Early research (Phase 1)Study completedNCT03289234
What this trial is testing

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy
Shionogi 22
Early research (Phase 1)Study completedNCT01762462
What this trial is testing

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Bristol-Myers Squibb 17
Early research (Phase 1)Study completedNCT01185873
What this trial is testing

Danoprevir in Healthy Volunteers And Patients With Hepatic Impairment

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 81
Early research (Phase 1)Study completedNCT05419635
What this trial is testing

Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function

Who this might be right for
Prevention of Thromboembolic EventsAtrial FibrillationAcute Myocardial Infarction+2 more
Bayer 27
Early research (Phase 1)Study completedNCT00139620
What this trial is testing

A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic Function

Who this might be right for
Advanced Solid Tumors
OSI Pharmaceuticals 39
Early research (Phase 1)Study completedNCT03282513
What this trial is testing

AG-120 (Ivosidenib) in Subjects With Mild or Moderate Hepatic Impairment or Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Agios Pharmaceuticals, Inc. 33
Early research (Phase 1)Active Not RecruitingNCT07193147
What this trial is testing

Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment

Who this might be right for
Diabetes
Gan & Lee Pharmaceuticals. 36
Early research (Phase 1)Study completedNCT05674474
What this trial is testing

Vorasidenib in Participants With Moderate or Mild Hepatic Impairment and Matched Participants With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Institut de Recherches Internationales Servier 16
Early research (Phase 1)Study completedNCT04552808
What this trial is testing

To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects

Who this might be right for
Hepatic Impairment
Sunshine Lake Pharma Co., Ltd. 16
Early research (Phase 1)Study completedNCT02524717
What this trial is testing

Evaluate the Pharmacokinetics of JNJ-56021927 in Participants With Mild or Moderate Hepatic Impairment Compared With Participants With Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Aragon Pharmaceuticals, Inc. 24
Early research (Phase 1)Study completedNCT02397707
What this trial is testing

Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

Who this might be right for
HCV Infection
Gilead Sciences 33
Not applicableStudy completedNCT05912933
What this trial is testing

Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)

Who this might be right for
Breast Cancer
Pfizer 1,342
Early research (Phase 1)Ended earlyNCT02050815
What this trial is testing

MEK162 in Healthy Subjects With Normal Hepatic Function and Subjects With Impaired Hepatic Function

Who this might be right for
Hepatic Impairment
Array Biopharma, now a wholly owned subsidiary of Pfizer 27
Early research (Phase 1)Study completedNCT06961643
What this trial is testing

Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Diabetes Mellitus
Shandong Suncadia Medicine Co., Ltd. 24
Early research (Phase 1)Study completedNCT05882032
What this trial is testing

LY3502970 in Participants With Impaired and Normal Liver Function

Who this might be right for
HealthyHepatic Insufficiency
Eli Lilly and Company 29
Early research (Phase 1)Study completedNCT03890809
What this trial is testing

An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage

Who this might be right for
Liver DysfunctionHealthy Volunteers
Bristol-Myers Squibb 32
Early research (Phase 1)Study completedNCT01563562
What this trial is testing

Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Hepatic ImpairmentHealthy
Biogen 34
Early research (Phase 1)Study completedNCT06093230
What this trial is testing

A Study in Subjects With Liver Function Injury and Subjects With Normal Liver Function

Who this might be right for
Subjects With Liver Function InjuryNormal Liver Function Subject
Shanghai Vinnerna Biosciences Co., Ltd. 24
Next Page